Long-Term Liabilities (Quarterly)

Long-Term Liabilities: The sum of all non-current liabilities.

bioAffinity Technologies, Inc. (BIAF) had Long-Term Liabilities of $1.10M for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$1.35M
Net Income	$-3.63M
Cost of Goods Sold	$0.93M
Gross Profit	$0.42M
Operating Expenses	$4.97M
Operating Income	$-3.62M
Non-Operating Income/Expense	$-0.01M
Pre-Tax Income	$-3.63M
Normalized Pre-Tax Income	$-3.63M
Income after Taxes	$-3.63M
Income from Continuous Operations	$-3.63M
Consolidated Net Income/Loss	$-3.63M
Normalized Income after Taxes	$-3.63M
EBIT	$-3.62M
EBITDA	$-3.50M
Weighted-Average Shares Outstanding (Basic)	4.49M
Weighted-Average Shares Outstanding (Diluted)	4.49M
Earnings per Share (EPS) (Basic)	$-0.81
Earnings per Share (EPS) (Diluted)	$-0.81
Balance Sheet Financials
Current Assets	$4.34M
Property, Plant, and Equipment	$0.25M
Long-Term Assets	$3.60M
Total Assets	$7.95M
Current Liabilities	$3.19M
Long-Term Debt	$0.55M
Long-Term Liabilities	$1.10M
Total Liabilities	$4.28M
Common Equity	$3.66M
Tangible Shareholders Equity	$1.55M
Shareholders Equity	$3.66M
Common Shares Outstanding	4.50M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-3.23M
Cash Flow from Investing Activities	$-0.01M
Cash Flow from Financial Activities	$-0.12M
Beginning Cash	$6.45M
End Cash	$3.10M
Increase/Decrease in Cash	$-3.35M
Stock-Based Compensation	$0.01M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.36
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.13
Debt to Equity Ratio	0.19
Gross Margin	31.29%
Operating Margin	-267.62%
EBIT Margin	-267.62%
EBITDA Margin	--
Pre-Tax Profit Margin	-268.63%
Profit Margin	-268.63%
Free Cash Flow	$-3.23M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.17
Inventory Turnover	11.92
Receiveable Turnover	1.97
Days Sales in Receivables	45.63
Return on Equity	-99.16%
Return on Tangible Equity	-233.53%
Return on Assets	-45.70%
Return on Investments	-86.13%
Book Value Per Share	$0.81
Free Cash Flow per Share	$-0.72
Operating Cash Flow per Share	$-0.72

Data from Zacks Investment Research, Inc.